Niels Junker

5PUBLICATIONS
38CO-AUTHORS
Epidemiological modellingSolid tumoursMolecular targetsPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 07, 2026
Cardiotoxicity, survival, and dexrazoxane use in patients with soft tissue sarcoma: a Danish population‑based cohort study.

|Apr 22, 2026
Increasing survival disparity between children, adolescents, and young adults with osteosarcoma or Ewing sarcoma of bone from 1990 to 2024: a population-based cohort study.

|Nov 17, 2025
β-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cells.

Klaire Yixin Fjæstad, Astrid Zedlitz Johansen, Hannes Linder

|Jun 29, 2023
Results of an Open-label, Phase Ia/b Study of Pembrolizumab plus Olaratumab in Patients with Unresectable, Locally Advanced, or Metastatic Soft-Tissue Sarcoma.

Patrick Schöffski, Rastislav Bahleda, Andrew J Wagner

|Dec 11, 2022
The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor.

Charlotte Margareta Brinch, Estrid Hogdall, Niels Junker

Pageof 1

Frequent Collaborators

3 joint publications

Ninna Aggerholm-Pedersen

2 joint publications

Michael Mørk Petersen

1 joint publications

Charlotte Margareta Brinch

1 joint publications

Estrid Hogdall